Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$396M |
| 2 |
JPMorgan Chase
JPM
|
+$167M |
| 3 |
Extra Space Storage
EXR
|
+$148M |
| 4 |
GE HealthCare
GEHC
|
+$120M |
| 5 |
Patterson-UTI
PTEN
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PDCE
PDC Energy, Inc.
PDCE
|
+$313M |
| 2 |
Super Micro Computer
SMCI
|
+$310M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
+$176M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$160M |
| 5 |
Walmart Inc
WMT
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.29% |
| 2 | Financials | 16.14% |
| 3 | Industrials | 13.23% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Healthcare | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Annexon
ANNX
$814M
| $138K | ﹤0.01% |
58,522
+16
| +0% | +$48 |
|
3277
Q32 Bio
QTTB
$467M
| $138K | ﹤0.01% |
6,534
-145
| -2% | -$2.96K |
|
3278
Comstock Holding Companies
CHCI
$157M
| $135K | ﹤0.01% |
28,804
-4,890
| -15% | -$21.8K |
|
3279
SelectQuote
SLQT
$132M
| $134K | ﹤0.01% |
114,277
-42,739
| -27% | -$64.5K |
|
3280
Exagen
XGN
$108M
| $133K | ﹤0.01% |
54,399
-13,462
| -20% | -$34.1K |
|
|
IMMP
3281
Immutep
IMMP
$57M
| $133K | ﹤0.01% |
70,005
-11,923
| -15% | -$24.2K |
|
|
SGMA
3282
DELISTED
Sigmatron International
SGMA
| $132K | ﹤0.01% |
42,054
-2,996
| -7% | -$15.2K |
|
|
AKTS
3283
DELISTED
Akoustis Technologies Inc
AKTS
| $131K | ﹤0.01% |
173,331
-142,170
| -45% | -$262K |
|
|
SRT
3284
DELISTED
Startek Inc.
SRT
| $131K | ﹤0.01% |
40,194
-7,937
| -16% | -$24.7K |
|
3285
Immunome
IMNM
$2.63B
| $129K | ﹤0.01% |
15,433
| – | – |
|
3286
Orion Energy Systems
OESX
$41.8M
| $129K | ﹤0.01% |
10,215
-8,398
| -45% | -$130K |
|
3287
Immuneering
IMRX
$274M
| $128K | ﹤0.01% |
+16,684
| New | +$153K |
|
|
CARM
3288
DELISTED
Carisma Therapeutics
CARM
| $128K | ﹤0.01% |
30,219
-933
| -3% | -$5.91K |
|
3289
Design Therapeutics
DSGN
$741M
| $128K | ﹤0.01% |
54,115
-5,520
| -9% | -$25.7K |
|
3290
Werewolf Therapeutics
HOWL
$21.8M
| $124K | ﹤0.01% |
58,128
+33,515
| +136% | +$92.4K |
|
3291
Jerash Holdings
JRSH
$57.5M
| $124K | ﹤0.01% |
41,262
| – | – |
|
|
THRX
3292
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $124K | ﹤0.01% |
46,153
-32,840
| -42% | -$129K |
|
3293
NextCure
NXTC
$22.1M
| $123K | ﹤0.01% |
7,977
-6,601
| -45% | -$126K |
|
3294
Patriot National Bancorp
PNBK
$129M
| $121K | ﹤0.01% |
17,024
| – | – |
|
3295
Shattuck Labs
STTK
$651M
| $116K | ﹤0.01% |
76,345
-371
| -0.5% | -$847 |
|
3296
Astrotech Corp
ASTC
$12.9M
| $114K | ﹤0.01% |
11,276
| – | – |
|
3297
Turkcell
TKC
$4.78B
| $113K | ﹤0.01% |
23,910
-5,017
| -17% | -$23.9K |
|
3298
Sypris Solutions
SYPR
$44.4M
| $113K | ﹤0.01% |
57,143
-5,324
| -9% | -$10.5K |
|
3299
Weave Communications
WEAV
$548M
| $112K | ﹤0.01% |
13,703
| – | – |
|
3300
KORU Medical Systems
KRMD
$184M
| $111K | ﹤0.01% |
40,985
-3,700
| -8% | -$10.1K |
|
Similar funds
Dimensional Fund Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Dimensional Fund Advisors held 3,560 positions worth $305B, down 2.8% from $314B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.9%. Dimensional Fund Advisors opened 80 new positions and exited 93, leaving the 3,560-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2023 buy was Kenvue: 17,128,393 shares worth $344M.
- Dimensional Fund Advisors added most to JPMorgan Chase in Q3 2023, an estimated $167M increase.
- Dimensional Fund Advisors's biggest Q3 2023 reduction was Super Micro Computer, cutting an estimated $310M.
- Dimensional Fund Advisors fully exited PDC Energy, Inc. in Q3 2023, selling an estimated $313M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $305B portfolio in Q3 2023.
- Dimensional Fund Advisors opened 80 new positions and closed 93 in Q3 2023.
- Dimensional Fund Advisors's portfolio value fell 2.8% quarter-over-quarter to $305B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.